Gut health boost may ease toxin burden in dialysis patients
NCT ID NCT07443280
First seen Apr 01, 2026 · Last updated May 20, 2026 · Updated 7 times
Summary
This study tests whether a 12-week multispecies synbiotic supplement can lower harmful gut-derived toxins and inflammation in 30 adults on hemodialysis. The goal is to improve gut health and reduce complications like heart disease. Participants must be on dialysis for at least 3 months and not have taken probiotics recently.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GUT MICROBIOTA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tungs' Taichung Metroharbour Hospital
Taichung, Wuqi District, 435, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.